Leung Pak Hou Anson
Director
management
Rui Kang Pharmaceutical Group Investments Ltd
Hong Kong
Biography
Leung Pak Hou Anson (“Mr. Anson Leung”), is Chief Compliance Officer, Executive Director of Rui Kang Pharmaceutical Group Investments Limited. He has been appointed as an executive Director since 15 May 2013 and has been the compliance officer of the Company since 30 May 2013. Mr. Anson Leung has experiences in dealing in securities, fund management, corporate management and corporate finance. He was employed by Jardine Fleming Holdings Limited from February 1994 to April 1998 and ABN AMRO Asset Management (Asia) Ltd from May 1998 to August 2000 respectively. He was also employed by CITIC Capital Markets Holdings Limited as manager from September 2000 to June 2002. Mr. Anson Leung has about 12 years of experience in the management and operation of manufacture and sales of medications in the pharmaceutical industry. Mr. Anson Leung is responsible for the overall corporate strategies and business development of the Group. He is also a director of a number of subsidiaries of the Company. Mr. Anson Leung graduated from University of Newcastle, Australia with his Bachelor of Commerce in April 1994. Mr. Anson Leung also obtained his Master of Business Administration from The University of Western Ontario, Canada in September 2001.
Research Interest
business and administration
